相关实验视频
Updated: Jun 4, 2025
05:25
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
635
在慢性冠状动脉综合征中进行皮肤冠状动脉再血管化的解剖与缺血驱动策略:一个网络元分析
Federico Giacobbe1, Eduardo Valente1, Giuseppe Giannino1
1Division of Cardiology, Department of Medical Science, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
概括
通过皮肤冠状动脉干预 (PCI) 以缺血评估为指导,无论是侵入性还是非侵入性,与单独的最佳医疗疗 (OMT) 相比,在慢性冠状动脉综合征 (CCS) 患者中减少重大不良临床事件 (MACE).
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
背景情况:
- 在慢性冠状动脉综合征 (CCS) 患者中,除了最佳医疗疗 (OMT) 之外,穿皮冠状动脉干预 (PCI) 的益处尚未完全确定.
- PCI策略可以根据血管造影结果或缺血评估来指导,因此需要对这些方法进行比较.
研究的目的:
- 为了比较不同PCI指导策略对CCS患者单独OMT的有效性.
- 评估缺血导向PCI与血管导向PCI对临床结果的影响.
主要方法:
- 进行了随机对照试验 (RCT) 的网络元分析.
- 研究比较了OMT单独与PCI指导的血管造影,非侵入性缺血评估或侵入性缺血评估.
- 主要终点是重大不良临床事件 (MACE);次要终点包括心血管死亡,心肌梗塞 (MI) 和无计划的再血管.
主要成果:
- 分析了18项涉及17512名患者的研究,平均随访时间为3.5年.
- 与单独OMT相比,缺血导向PCI (侵入性和非侵入性) 显著降低了MACE.
- 非侵入性缺血导向的PCI降低了心脏病发作风险 (HR:0.61),侵入性评估 (iFR,FFR) 显示降低重血管化需求的可能性最高.
结论:
- 使用侵入性或非侵入性方法的缺血导向PCI,在减少CCS患者的MACE方面优于单独OMT.
- 缺血评估的选择影响了结果,非侵入性测试改善了心脏病发作风险,侵入性评估 (iFR,FFR) 最好用于预防再血管.
相关概念视频
01:17Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
452
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
452